14792 related articles for article (PubMed ID: 28385173)
1. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
2. A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine.
Martiny K; Refsgaard E; Lund V; Lunde M; Sørensen L; Thougaard B; Lindberg L; Bech P
J Clin Psychiatry; 2012 Sep; 73(9):1234-42. PubMed ID: 23059149
[TBL] [Abstract][Full Text] [Related]
3. Maintained superiority of chronotherapeutics vs. exercise in a 20-week randomized follow-up trial in major depression.
Martiny K; Refsgaard E; Lund V; Lunde M; Thougaard B; Lindberg L; Bech P
Acta Psychiatr Scand; 2015 Jun; 131(6):446-57. PubMed ID: 25689725
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.
Martiny K; Lunde M; Undén M; Dam H; Bech P
Acta Psychiatr Scand; 2005 Aug; 112(2):117-25. PubMed ID: 15992393
[TBL] [Abstract][Full Text] [Related]
5. The day-to-day acute effect of wake therapy in patients with major depression using the HAM-D6 as primary outcome measure: results from a randomised controlled trial.
Martiny K; Refsgaard E; Lund V; Lunde M; Sørensen L; Thougaard B; Lindberg L; Bech P
PLoS One; 2013; 8(6):e67264. PubMed ID: 23840645
[TBL] [Abstract][Full Text] [Related]
6. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
7. Dose-remission of pulsating electromagnetic fields as augmentation in therapy-resistant depression: a randomized, double-blind controlled study.
Straasø B; Lauritzen L; Lunde M; Vinberg M; Lindberg L; Larsen ER; Dissing S; Bech P
Acta Neuropsychiatr; 2014 Oct; 26(5):272-9. PubMed ID: 25241755
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
9. Comparison of venlafaxine alone versus venlafaxine plus bright light therapy combination for severe major depressive disorder.
Güzel Özdemir P; Boysan M; Smolensky MH; Selvi Y; Aydin A; Yilmaz E
J Clin Psychiatry; 2015 May; 76(5):e645-54. PubMed ID: 26035199
[TBL] [Abstract][Full Text] [Related]
10. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
12. Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression.
Martiny K; Lunde M; Bech P
Biol Psychiatry; 2010 Jul; 68(2):163-9. PubMed ID: 20385376
[TBL] [Abstract][Full Text] [Related]
13. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
14. Exercise therapy for chronic fatigue syndrome.
Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
Cochrane Database Syst Rev; 2015 Feb; (2):CD003200. PubMed ID: 25674924
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression.
Wirz-Justice A; Bader A; Frisch U; Stieglitz RD; Alder J; Bitzer J; Hösli I; Jazbec S; Benedetti F; Terman M; Wisner KL; Riecher-Rössler A
J Clin Psychiatry; 2011 Jul; 72(7):986-93. PubMed ID: 21535997
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
17. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
Berlim MT; Van den Eynde F; Daskalakis ZJ
J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
[TBL] [Abstract][Full Text] [Related]
18. Bright light treatment of depression for older adults [ISRCTN55452501].
Loving RT; Kripke DF; Elliott JA; Knickerbocker NC; Grandner MA
BMC Psychiatry; 2005 Nov; 5():41. PubMed ID: 16283925
[TBL] [Abstract][Full Text] [Related]
19. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo.
Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC
Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
